Stock Overview

STERIS plc (STE)

NYSE · Healthcare · Medical Devices

STERIS plc is a Healthcare company with a market capitalization of $21.02B, a trailing P/E ratio of 27.2, and a dividend yield of 1.17%.

Market Cap
$21.02B
P/E (TTM)
27.2
Forward P/E
18.9
Price/Sales
3.5
Price/Book
2.9
EV/EBITDA
13.9
Dividend Yield
1.17%
Beta
0.92
EPS (TTM)
$7.94
Profit Margin
13.2%
ROE
11.4%
52W High
$267.96
52W Low
$194.56

5-Year Price History

Latest Annual Financials · FY ending March 31, 2026

Revenue
$5.94B
Gross Profit
$2.63B
Operating Income
$1.10B
Net Income
$785.10M
Free Cash Flow
$972.40M
Total Debt
$1.97B
Cash & Equivalents
$439.60M
Shareholder Equity
$7.18B

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q4 2026May 11, 2026$2.83$2.85-0.7%
Q3 2025February 4, 2026$2.53$2.53+0.0%
Q2 2025November 5, 2025$2.47$2.35+5.1%
Q1 2025August 6, 2025$2.34$2.26+3.5%
Q4 2025May 14, 2025$2.74$2.60+5.4%
Q3 2024February 5, 2025$2.32$2.32+0.0%

Other Medical Devices Stocks

Frequently Asked Questions

What is STERIS plc's market cap?

As of June 29, 2026, STERIS plc (STE) has a market capitalization of $21.02B.

What is STERIS plc's P/E ratio?

STERIS plc trades at a trailing price-to-earnings (P/E) ratio of 27.2. Its forward P/E is 18.9.

Does STERIS plc pay a dividend?

Yes — STERIS plc pays a dividend yielding 1.17%, an annual payout of $2.46 per share.

What sector is STE in?

STERIS plc is in the Healthcare sector, specifically the Medical Devices industry.

What was STERIS plc's revenue?

In its latest reported fiscal year (ending March 31, 2026), STERIS plc reported revenue of $5.94B and net income of $785.10M.

Ask your own questions about STE

Try mrmarket.ai free

Data as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.